Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surgery for primary cutaneous malignant melanoma.

D F Roses, M N Harris, S L Gumport

    Dermatologic Clinics
    |April 1, 1985
    PubMed
    Summary

    Elective regional lymph node dissection is not recommended for thin melanomas (<1.0 mm), those in the midline, elderly/unwell patients, or those with metastases. Surgery remains key for melanoma treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Implementation of an electronic data monitoring system decreases the rate of hyperoxic episodes in premature neonates.

    Journal of perinatology : official journal of the California Perinatal Association·2013
    Same author

    Concentrations of nonesterified fatty acids and glucose in blood of periparturient dairy cows are indicative of pregnancy success at first insemination.

    Journal of dairy science·2012
    Same author

    Numerical abnormalities of chromosomes 7, 18, and x in precancerous breast disease defined by fluorescent in situ hybridization.

    The breast journal·2011
    Same author

    Elective radiation therapy for high-risk malignant melanomas.

    Cancer journal (Sudbury, Mass.)·2002
    Same author

    Double-blind trial of a polyvalent, shed-antigen, melanoma vaccine.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2001
    Same author

    Poland's syndrome and carcinoma of the breast: a case report.

    The breast journal·2001

    Area of Science:

    • Oncology
    • Surgical Oncology
    • Dermatology

    Background:

    • Malignant melanoma is a potentially fatal neoplasm.
    • Surgical management, including lymph node dissection, is crucial for melanoma treatment.
    • Determining the optimal approach for elective regional lymph node dissection (eRLND) is essential for patient outcomes.

    Purpose of the Study:

    • To define specific clinical scenarios where eRLND is not typically indicated in malignant melanoma management.
    • To outline the therapeutic and prognostic advantages of eRLND in remaining patient groups.
    • To establish a prudent follow-up strategy for patients not undergoing eRLND.

    Main Methods:

    • Retrospective review of clinical data and treatment outcomes.
    • Analysis of melanoma thickness, location, patient comorbidities, and metastatic status.
    • Evaluation of the morbidity and therapeutic impact of eRLND.

    Main Results:

    • eRLND is generally not advised for in situ or thin (<1.0 mm) melanomas due to low metastasis rates.
    • Bilateral nodal dissections are not justified for midline head/neck or trunk melanomas without clear benefit.
    • eRLND should be avoided in elderly or very ill patients unless the melanoma is thick and directly over a nodal group; it's also contraindicated in patients with systemic metastases.

    Conclusions:

    • Specific criteria exist to guide the decision against eRLND, optimizing patient care and avoiding unnecessary morbidity.
    • For eligible patients, eRLND offers therapeutic and prognostic advantages and should be considered primary therapy if performed with minimal morbidity.
    • Close clinical surveillance is recommended for patients not undergoing eRLND, with surgery remaining the primary treatment for localized melanoma until effective systemic therapies are available.

    Related Experiment Videos